Jerry Arellano is a Cardiology physician. OpenAlex indexes 5 publications with 425 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2601 N Tenaya Way
Las Vegas, NV 891280427
Telephone
702-240-8155Provider last certified this registry record 4 Mar 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202315 payments
- Medtronic, Inc.Program year20222 payments
- Abbott LaboratoriesProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.2%Beta blocker29.4%Metoprolol Succinate70%Metoprolol Tartrate18%Atenolol12%Part D<11 patientsAntiarrhythmic17.3%Flecainide Acetate63%Amiodarone Hcl37%Part D≥25 patients+ 9 more classes in this area
Blood & clotting
9.4%Direct thrombin inhibitors6.8%Pradaxa100%Part D≥14 patientsFactor Xa inhibitor2.7%Eliquis100%Part D<11 patientsAnti-infectives
3.4%Penicillins with extended spectrum3.4%Amoxicillin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable
Pacing and Clinical Electrophysiology
2009 - The Impact of Insulin Resistance on Macrophage Death Pathways in Advanced Atherosclerosis
Novartis Foundation symposium
2007 - Yeast Transcript Elongation Factor (TFIIS), Structure and Function
Journal of Biological Chemistry
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”